Boston Scientific Stock News

Key Players Covered in the Long Term Care Technology Market Research Report Are Medline Industries Inc. (U.S.), Medtronic (Ireland), B. Braun Melsungen AG (Germany), 3M (U.S.), Baxter (U.S.), ARKRAY Inc. (Japan), BD (U.S.), Omron Healthcare Inc. (Japan), Koninklijke Philips N.V. (Netherlands), GENERAL ELECTRIC COMPANY (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Cardinal Health (U.S.), Boston Scientific Corporation (U.S.), Honeywell International Inc. (U.S.) and other key market players. Key Players Covered in the Long Term Care Technology Market Research Report Are Medline Industries Inc. (U.S.), Medtronic (Ireland), B. Braun Melsungen AG (Germany), 3M (U.S.), Baxter (U.S.), ARKRAY Inc. (Japan), BD (U.S.), Omron Healthcare Inc. (Japan), Koninklijke Philips N.V. (Netherlands), GENERAL ELECTRIC COMPANY (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Cardinal Health (U.S.), Boston Scientific Corporation (U.S.), Honeywell International Inc. (U.S.) and other key market players.

The Embolization Products Market research report includes the competitive landscape that involves leading companies and adopting strategies to introduce new products, announce partnerships, and collaborate to contribute to market growth. Moreover, the report elaborates on numerous customers journeys related to

The Medical Guide Wire report provides overall structure and business outlook of the global and regional industries. The study also involves the important Achievements of the market, Research & Development, new product launch, product responses and regional growth of the

Trust Asset Management LLC lifted its holdings in shares of Boston Scientific Co. (NYSE:BSX) by 7.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 13,692 shares of the medical equipment providers stock after acquiring an additional 921 shares during the period. Trust Asset Management LLCs holdings in Boston Scientific were worth $594,000 as []

Cornerstone Wealth Group LLC bought a new position in Boston Scientific Co. (NYSE:BSX) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 108,777 shares of the medical equipment providers stock, valued at approximately $4,720,000. Boston Scientific accounts for approximately 0.8% of Cornerstone Wealth Group LLCs investment portfolio, making []

Vontobel Holding Ltd. trimmed its position in Boston Scientific Co. (NYSE:BSX) by 1.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 503,246 shares of the medical equipment providers stock after selling 9,440 shares during the period. Vontobel Holding Ltd.s holdings []

Boston Scientific Co. (NYSE:BSX) SVP Wendy Carruthers sold 3,321 shares of the companys stock in a transaction dated Wednesday, December 15th. The stock was sold at an average price of $40.83, for a total transaction of $135,596.43. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at []

The Lithotripsy Devices Market research report presents a top-notch analysis that incorporates market restaurants, drivers, and opportunities available in the market. The report also segments the market by how a competitive environment is developed among leading players across the globe.

Boston Scientific Corporation (NYSE:BSX) shares, rose in value at last check on Thursday, 12/16/21, with the stock price up by 1.59% to the previous day’s close as strong demand from buyers drove the stock to $40.88. Actively observing the price movement in the recent trading, the stock is buoying the session at $40.24, falling within … Boston Scientific Corporation (NYSE: BSX) Jumps 1.59%: Is This A Sign Of Things To Come? Read More »

Boston Scientific's (BSX) new acquisitions like Preventice, Farapulse and Lumenis Surgical, which closed in March, August and September of 2021, respectively, are contributing to its inorganic growth.

BNC Wealth Management LLC increased its holdings in Boston Scientific Co. (NYSE:BSX) by 6.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,045 shares of the medical equipment providers stock after acquiring an additional 1,343 shares during the []

Boston Scientific's (BSX) new acquisitions like Preventice, Farapulse and Lumenis Surgical, which closed in March, August and September of 2021, respectively, are contributing to its inorganic growth.

ReportsnReports has uploaded a latest report on Peripheral Intravascular Ultrasound (IVUS) Catheter Industry from its research database. Peripheral Intravascular Ultrasound (IVUS) Catheter Market is segmented by Regions/Countries. All the key market aspects that influence the Peripheral Intravascular Ultrasound (IVUS)

DUBLIN--(BUSINESS WIRE)--The "Smart Drugs & Pills Market Research Report by Target Area, End-user, Application, and State - United States Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com''s offering. The United States Smart Drugs & Pills Market size was estimated at USD 685.62 million in 2020, is expected to reach USD 867.25 million in 2021, and is projected to grow at a CAGR of 23.38% reaching USD 2,419.22 million by 2026. Market Statisti

Shares of Boston Scientific Co. (NYSE:BSX) have been given a consensus recommendation of Buy by the sixteen brokerages that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The []